Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 33 (N.D.W.Va. May. 24, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 33 (N.D.W.Va. May. 24, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 24 (N.D.W.Va. May. 9, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 24 (N.D.W.Va. May. 9, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 17 (N.D.W.Va. Mar. 29, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 17 (N.D.W.Va. Mar. 29, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 15 (N.D.W.Va. Mar. 29, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 15 (N.D.W.Va. Mar. 29, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 16 (N.D.W.Va. Mar. 29, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 16 (N.D.W.Va. Mar. 29, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 18 (N.D.W.Va. Mar. 29, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 18 (N.D.W.Va. Mar. 29, 2022)
+ More Snippets
Document
IPR2023-00723, No. 9 Institution Decision Deny - Denying Institution of Inter Partes Review 35 USC § 314 (P.T.A.B. Oct. 2, 2023)
Cite Document
IPR2023-00723, No. 9 Institution Decision Deny - Denying Institution of Inter Partes Review 35 USC § 314 (P.T.A.B. Oct. 2, 2023)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 8 (N.D.W.Va. Mar. 28, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 8 (N.D.W.Va. Mar. 28, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 7 (N.D.W.Va. Mar. 25, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 7 (N.D.W.Va. Mar. 25, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 36 (N.D.W.Va. Jun. 14, 2023)
Cite Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 36 (N.D.W.Va. Jun. 14, 2023)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 33 (N.D.W.Va. Jun. 1, 2023)
Cite Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 33 (N.D.W.Va. Jun. 1, 2023)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 31 (N.D.W.Va. May. 17, 2023)
Cite Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 31 (N.D.W.Va. May. 17, 2023)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 29 (N.D.W.Va. May. 3, 2023)
Cite Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 29 (N.D.W.Va. May. 3, 2023)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 28 (N.D.W.Va. Apr. 21, 2023)
Cite Document
Novo Nordisk, Inc. et al v. Viatris Inc. et al, 1:23-cv-00013, No. 28 (N.D.W.Va. Apr. 21, 2023)
+ More Snippets
Document
IPR2023-00723, No. 5 Notice Notice filing date accorded - Notice Notice filing date accorded (P.T.A.B. Apr. 6, 2023)
Cite Document
IPR2023-00723, No. 5 Notice Notice filing date accorded - Notice Notice filing date accorded (P.T.A.B. Apr. 6, 2023)
+ More Snippets